| Oct 13 2018 |
EU-OSHA Posts Info Sheet on Manufactured Nanomaterials in the Workplace |
Bergeson & Campbell, P.C. |
| Oct 12 2018 |
Police Officer’s Disclosure of Adderall Prescription Insufficient to Support Disability Discrimination Claim |
Jackson Lewis P.C. |
| Oct 12 2018 |
TTB Publishes Updated Guidelines for Formula Approvals for Domestic Producers and Importers |
McDermott Will & Schulte LLP |
| Oct 12 2018 |
What “Bio-based” Means Across The Globe |
Bergeson & Campbell, P.C. |
| Oct 12 2018 |
Germany Publishes Study on Health Effects of Ultrafine Particles |
Bergeson & Campbell, P.C. |
| Oct 11 2018 |
FDA Issues Draft Guidance on Expanding Special 510(K) Program |
Barnes & Thornburg LLP |
| Oct 11 2018 |
USDA Secretary Signals USDA Role Over Animal Cell Culture Technology Regulation Ahead of Joint USDA-FDA Meeting |
Keller and Heckman LLP |
| Oct 10 2018 |
EPA Publishes SNUR for Single-Walled Carbon Nanotubes |
Bergeson & Campbell, P.C. |
| Oct 10 2018 |
FDA Adds Eight New Substances to its Inventory of Effective FCS Notifications - October 2018 |
Keller and Heckman LLP |
| Oct 10 2018 |
FDA Removes Clearance for Styrene and Other Synthetic Flavoring Substances |
Keller and Heckman LLP |
| Oct 10 2018 |
Flavored Sparkling Water, LaCroix, Sued Over Natural Claims |
Keller and Heckman LLP |
| Oct 9 2018 |
Sunshine Act Expands to Advance Practice Nurses and Physician Assistants |
Mintz |
| Oct 9 2018 |
Celebrating the Promise of Parity and the Path Forward |
Mintz |
| Oct 9 2018 |
Canada’s New Regulatory Framework for Vaping Products |
Keller and Heckman LLP |
| Oct 9 2018 |
FDA Removes Clearance for 7 Synthetic Flavoring Substances |
Keller and Heckman LLP |
| Oct 8 2018 |
California Adopts Statewide Producer-Funded Pharmaceutical Household Drug and Sharps Take-Back Program |
Beveridge & Diamond PC |
| Oct 8 2018 |
New CBMA Guidance Further Clarifies Excise Tax Rules for Imported Beverages |
McDermott Will & Schulte LLP |
| Oct 8 2018 |
Health Care Enforcement Quarterly Roundup - October 2018 |
McDermott Will & Schulte LLP |
| Oct 6 2018 |
The New Jersey Supreme Court’s Latest Decision Affecting Pharmaceutical Multicounty Litigation |
Stark & Stark |
| Oct 5 2018 |
MERCOSUR Revised Resolution on Additives for Plastic FCMs in Final Review |
Keller and Heckman LLP |
| Oct 5 2018 |
DEA Schedules a FDA-Approved CBD Drug |
McDermott Will & Schulte LLP |
| Oct 5 2018 |
Final Opioid Legislation Expands Treatment Options for Medicaid Beneficiaries with Substance Use Disorder |
Mintz |
| Oct 5 2018 |
The Week Ahead in the European Parliament – October 5, 2018 |
Covington & Burling LLP |
| Oct 5 2018 |
FDA Issues Final Guidance on Medical Device Benefit and Risk Analysis for 510(K)S |
Barnes & Thornburg LLP |
| Oct 5 2018 |
Special Ruling Aimed At Restricting NJ Craft Breweries Indefinitely Suspended |
Stark & Stark |
| Oct 5 2018 |
FDA Collects Thousands of Pages of Documents in Inspection of JUUL Labs |
Keller and Heckman LLP |
| Oct 5 2018 |
UK Government Issues “No Deal” Brexit Notices for the Food & Beverage Sector |
Covington & Burling LLP |
| Oct 4 2018 |
Selling CBD Products is Illegal, Ohio Board of Pharmacy Clarifies |
Dinsmore & Shohl LLP |
| Oct 4 2018 |
Industry Group Agrees to Stricter Nutrition Criteria for Foods Advertised to Children under 12 |
Keller and Heckman LLP |
| Oct 3 2018 |
Delaware Court Finds “Material Adverse Effect” Allows Buyer to Terminate Merger Agreement: Akorn, Inc. v. Fresenius Kabi AG |
Mintz |
| Oct 3 2018 |
EPA Releases Working Approach for Identifying Potential Candidate Chemicals for Prioritization under TSCA |
Bergeson & Campbell, P.C. |
| Oct 3 2018 |
Cannabis Advertising |
Womble Bond Dickinson (US) LLP |
| Oct 3 2018 |
EPA Requests Public Nominations for FIFRA SAP; Requests Independent Scientific Advice on Health and Safety Issues |
Bergeson & Campbell, P.C. |
| Oct 3 2018 |
FDA Finds Exposure to Pesticides and Glyphosate in Food Samples Below Federal Limits |
Keller and Heckman LLP |
| Oct 2 2018 |
EPA Will Publish SNUR for Carbon Nanomaterial (Generic) |
Bergeson & Campbell, P.C. |
